Literature DB >> 20184571

Changes in specific domains of sexual function and sexual bother after radical prostatectomy.

Jesse D Le1, Matthew R Cooperberg, Natalia Sadetsky, Adam B Hittelman, Maxwell V Meng, Janet E Cowan, David M Latini, Peter R Carroll.   

Abstract

OBJECTIVE: To quantitatively assess the effect of radical prostatectomy (RP) on the specific domains that comprise overall sexual function (SF), focusing on the relationships among these domains and overall SF, and to identify predictors for recovery of SF over time, as a decline in SF and sexual bother (SB) are known potential complications of treatment for prostate cancer. PATIENTS AND METHODS: Within the Cancer of the Prostate Strategic Urologic Research Endeavor database, we identified men diagnosed between 1995 and 2001 with localized prostate cancer treated with RP. SF and SB outcomes, measured using the University of California Los Angeles Prostate Cancer Index, were assessed at 6-month intervals for 4 years after RP.
RESULTS: In all, 620 men met the study criteria; at 6 months after RP, overall and all the specific domains of SF declined, with improvement in most specific domains by 2 years after RP. The greatest declines were in the ability to achieve erections, high-quality erections, and frequent erections; these domains were also most strongly correlated with overall SF. Sexual desire was relatively preserved, and there was a weak correlation between overall SF and sexual desire after RP, when there was the greatest discrepancy between sexual desire and other domains of function. SB showed continued improvement over time to 4 years but was not well correlated with any measurements of SF assessed. Younger age, college education, sexual aid and medication use, the absence of comorbid conditions, and nerve-sparing surgery were predictive of significant recovery of function in several specific domains of SF.
CONCLUSIONS: RP affects specific domains of SF to differing degrees. Compromised erectile function is most commonly reported among these specific domains and seems to play a more dominant role in determining overall SF, but notably none of the domains of function were closely linked to SB. Because education is protective in the perception of bother, appropriate counselling and the setting of expectations for outcomes in overall and specific domains of SF might lead to improved quality of life after treatment for prostate cancer.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20184571     DOI: 10.1111/j.1464-410X.2010.09231.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

1.  A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment.

Authors:  Leslie R Schover; Andrea L Canada; Ying Yuan; Dawen Sui; Leah Neese; Rosell Jenkins; Michelle M Rhodes
Journal:  Cancer       Date:  2011-09-26       Impact factor: 6.860

Review 2.  Role of regenerative therapies on erectile dysfunction after radical prostatectomy.

Authors:  S T Hansen; M Lund; L D Ostergaard; L Lund
Journal:  Int J Impot Res       Date:  2021-01-15       Impact factor: 2.896

3.  Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy.

Authors:  Justin K Lee; Melissa Assel; Alan E Thong; Daniel D Sjoberg; John P Mulhall; Jaspreet Sandhu; Andrew J Vickers; Behfar Ehdaie
Journal:  Eur Urol       Date:  2015-08-17       Impact factor: 20.096

4.  Health-related quality of life following radical prostatectomy: long-term outcomes.

Authors:  Andrew G Matthew; Shabbir M H Alibhai; Tal Davidson; Kristen L Currie; Haiyan Jiang; Murray Krahn; Neil E Fleshner; Robin Kalnin; Alyssa S Louis; B Joyce Davison; John Trachtenberg
Journal:  Qual Life Res       Date:  2014-03-09       Impact factor: 4.147

5.  Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.

Authors:  Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-06-27       Impact factor: 3.894

6.  Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?

Authors:  Sanoj Punnen; Matthew R Cooperberg; Natalia Sadetsky; Peter R Carroll
Journal:  BJU Int       Date:  2011-10-14       Impact factor: 5.588

7.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

Review 8.  Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Authors:  Ronald C Chen; Peter Chang; Richard J Vetter; Himansu Lukka; William A Stokes; Martin G Sanda; Deborah Watkins-Bruner; Bryce B Reeve; Howard M Sandler
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

Review 9.  Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors.

Authors:  Ateş Kadıoğlu; Mazhar Ortaç; Gerald Brock
Journal:  Transl Androl Urol       Date:  2015-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.